Annual EBITDA:
-$199.81M-$73.87M(-58.65%)Summary
- As of today, PRAX annual EBITDA is -$199.81 million, with the most recent change of -$73.87 million (-58.65%) on December 31, 2024.
- During the last 3 years, PRAX annual EBITDA has fallen by -$32.66 million (-19.54%).
- PRAX annual EBITDA is now -660.47% below its all-time high of -$26.27 million, reached on December 31, 2018.
Performance
PRAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$76.02M-$1.34M(-1.79%)Summary
- As of today, PRAX quarterly EBITDA is -$76.02 million, with the most recent change of -$1.34 million (-1.79%) on June 30, 2025.
- Over the past year, PRAX quarterly EBITDA has dropped by -$38.64 million (-103.37%).
- PRAX quarterly EBITDA is now -915.78% below its all-time high of -$7.48 million, reached on December 31, 2019.
Performance
PRAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$271.35M-$38.64M(-16.60%)Summary
- As of today, PRAX TTM EBITDA is -$271.35 million, with the most recent change of -$38.64 million (-16.60%) on June 30, 2025.
- Over the past year, PRAX TTM EBITDA has dropped by -$139.10 million (-105.17%).
- PRAX TTM EBITDA is now -2449.36% below its all-time high of -$10.64 million, reached on September 30, 2019.
Performance
PRAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PRAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -58.6% | -103.4% | -105.2% |
| 3Y3 Years | -19.5% | -26.1% | -16.8% |
| 5Y5 Years | -458.9% | -557.6% | -520.8% |
PRAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -58.6% | +6.9% | -199.2% | at low | -115.5% | at low |
| 5Y | 5-Year | -458.9% | +6.9% | -369.1% | at low | -520.8% | at low |
| All-Time | All-Time | -660.5% | +6.9% | -915.8% | at low | -2449.4% | at low |
PRAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$76.02M(-1.8%) | -$271.35M(-16.6%) |
| Mar 2025 | - | -$74.68M(-16.9%) | -$232.71M(-16.5%) |
| Dec 2024 | -$199.81M(-58.7%) | -$63.91M(-12.6%) | -$199.81M(-22.1%) |
| Sep 2024 | - | -$56.74M(-51.8%) | -$163.59M(-23.7%) |
| Jun 2024 | - | -$37.38M(+10.5%) | -$132.26M(-1.9%) |
| Mar 2024 | - | -$41.77M(-50.8%) | -$129.73M(-3.0%) |
| Dec 2023 | -$125.94M(+41.3%) | -$27.70M(-9.0%) | -$125.94M(+9.8%) |
| Sep 2023 | - | -$25.41M(+27.1%) | -$139.59M(+11.9%) |
| Jun 2023 | - | -$34.85M(+8.2%) | -$158.38M(+13.8%) |
| Mar 2023 | - | -$37.98M(+8.1%) | -$183.80M(+14.3%) |
| Dec 2022 | -$214.57M | -$41.35M(+6.4%) | -$214.57M(+7.4%) |
| Sep 2022 | - | -$44.19M(+26.7%) | -$231.78M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$60.27M(+12.3%) | -$232.33M(-11.4%) |
| Mar 2022 | - | -$68.76M(-17.4%) | -$208.51M(-24.7%) |
| Dec 2021 | -$167.15M(-170.0%) | -$58.56M(-30.9%) | -$167.15M(-24.5%) |
| Sep 2021 | - | -$44.73M(-22.7%) | -$134.28M(-27.0%) |
| Jun 2021 | - | -$36.46M(-33.1%) | -$105.75M(-30.8%) |
| Mar 2021 | - | -$27.40M(-6.6%) | -$80.86M(-30.6%) |
| Dec 2020 | -$61.92M(-73.2%) | -$25.69M(-58.5%) | -$61.92M(-41.7%) |
| Sep 2020 | - | -$16.21M(-40.2%) | -$43.71M(-14.6%) |
| Jun 2020 | - | -$11.56M(-36.7%) | -$38.15M(-43.5%) |
| Mar 2020 | - | -$8.46M(-13.0%) | -$26.59M(-46.7%) |
| Dec 2019 | -$35.75M(-36.1%) | -$7.48M(+29.7%) | -$18.13M(-70.3%) |
| Sep 2019 | - | -$10.64M | -$10.64M |
| Dec 2018 | -$26.27M | - | - |
FAQ
- What is Praxis Precision Medicines, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. annual EBITDA year-on-year change?
- What is Praxis Precision Medicines, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. quarterly EBITDA year-on-year change?
- What is Praxis Precision Medicines, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Praxis Precision Medicines, Inc.?
- What is Praxis Precision Medicines, Inc. TTM EBITDA year-on-year change?
What is Praxis Precision Medicines, Inc. annual EBITDA?
The current annual EBITDA of PRAX is -$199.81M
What is the all-time high annual EBITDA for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high annual EBITDA is -$26.27M
What is Praxis Precision Medicines, Inc. annual EBITDA year-on-year change?
Over the past year, PRAX annual EBITDA has changed by -$73.87M (-58.65%)
What is Praxis Precision Medicines, Inc. quarterly EBITDA?
The current quarterly EBITDA of PRAX is -$76.02M
What is the all-time high quarterly EBITDA for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high quarterly EBITDA is -$7.48M
What is Praxis Precision Medicines, Inc. quarterly EBITDA year-on-year change?
Over the past year, PRAX quarterly EBITDA has changed by -$38.64M (-103.37%)
What is Praxis Precision Medicines, Inc. TTM EBITDA?
The current TTM EBITDA of PRAX is -$271.35M
What is the all-time high TTM EBITDA for Praxis Precision Medicines, Inc.?
Praxis Precision Medicines, Inc. all-time high TTM EBITDA is -$10.64M
What is Praxis Precision Medicines, Inc. TTM EBITDA year-on-year change?
Over the past year, PRAX TTM EBITDA has changed by -$139.10M (-105.17%)